Parallax Volatility Advisers, L.P. Astrazeneca PLC Call Options Transaction History

Parallax Volatility Advisers, L.P.

$53.5 Billion
Q3 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $42.6 Million - $48.7 Million	555,600 Added 365.77%	707,500 $55.1 Million
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $29.3 Million - $35.4 Million	-438,300 Reduced 74.26%	151,900 $11.8 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $6.1 Million - $6.95 Million	99,900 Added 20.38%	590,200 $40 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $21.9 Million - $24.5 Million	354,300 Added 260.51%	490,300 $33 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $5.02 Million - $5.55 Million	77,400 Added 132.08%	136,000 $9.21 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $678,127 - $735,357	-9,700 Reduced 14.2%	58,600 $4.19 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $486,255 - $551,320	-7,700 Reduced 10.13%	68,300 $4.74 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $6.98 Million - $9.07 Million	-128,800 Reduced 62.89%	76,000 $5.15 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $6.15 Million - $15.7 Million	115,900 Added 130.37%	204,800 $11.2 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $1.25 Million - $1.5 Million	21,100 Added 31.12%	88,900 $5.87 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $11.6 Million - $14 Million	-208,300 Reduced 75.44%	67,800 $4.5 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $4.18 Million - $4.94 Million	-77,400 Reduced 21.9%	276,100 $16.1 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $6.32 Million - $6.91 Million	113,700 Added 47.41%	353,500 $21.2 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $23.7 Million - $29.5 Million	-490,200 Reduced 67.15%	239,800 $14.4 Million
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $28.6 Million - $33.1 Million	607,400 Added 495.43%	730,000 $36.3 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $970,400 - $1.16 Million	20,000 Added 19.49%	122,600 $6.13 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $19.9 Million - $22.9 Million	-375,400 Reduced 78.54%	102,600 $5.62 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $20.6 Million - $26.4 Million	477,000 Added 47700.0%	478,000 $25.3 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $748,839 - $907,722	-21,100 Reduced 95.48%	1,000 $40,000
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $1.06 Million - $1.21 Million	-30,400 Reduced 57.9%	22,100 $874,000
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $1.19 Million - $1.28 Million	34,500 Added 191.67%	52,500 $1.84 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $9.23 Million - $10.3 Million	-280,000 Reduced 93.96%	18,000 $629,000
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $253,511 - $274,762	7,900 Added 2.72%	298,000 $10.3 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $8.4 Million - $9.86 Million	290,100	290,100 $9.83 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.07 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.41 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.38 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.24 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account